Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2021 Financial Results

Go back to Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2021 Financial Results
(NASDAQ: VIR) Delayed: 10.37 -0.01 (0.1%)
Previous Close $10.38    52 Week High
Open $10.41    52 Week Low
Day High $10.54    P/E N/A 
Day Low $10.25    EPS
Volume 690,380